The Jackson Laboratory, founded in 1929 and based in the United States, operates within the business services sector, focusing primarily on research and development in the fields of genetics and cancer. With a workforce of 1,001 to 5,000 employees, the organization generates significant revenue, indicating its substantial role in the biotech and pharmaceutical industries. The laboratory is dedicated to advancing the understanding of hereditary cancer, as evidenced by its published case study that explores the implications of genetic variants, such as those in the CDKN2A gene, which are linked to increased cancer risk. This case study illustrates the practical application of genomic data in clinical settings, showcasing the laboratory's commitment to integrating research findings into healthcare practices. The Jackson Laboratory also engages in educational initiatives and corporate services, further emphasizing its multifaceted approach to research and development in the life sciences. The organization is recognized for its contributions to non-profit management, particularly in the context of advancing cancer genetics research and education.